Sort   by:  
 Page size 
UnknownInhibition of CBP/β-catenin signaling ameliorated fibrosis in cholestatic liver disease.
Not available
S-EPMC9512479 | biostudies-literature
Unknownβ-Catenin/CBP-Dependent Signaling Regulates TGF-β-Induced Epithelial to Mesenchymal Transition of Lens Epithelial Cells.
Not available
S-EPMC5089212 | biostudies-literature
TranscriptomicsTargeting oncogenic β-catenin/CBP activity for the treatment of head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) presents primarily as oral squamous cell carcinoma (OSCC), an aggressive malignancy characterized by heterogeneity, locoregional metastases and resistance to existing treatments. Although a number of molecular alterations associated with OSCC have been i...
ORGANISM(S): Homo sapiens 
2018-07-03 | GSE95704 | GEO
Transcriptomicsβ-catenin signaling is a critical event in ErbB2-mediated mammary tumor progression.
Although ERBB2 amplification and overexpression is correlated with poor outcome in breast cancer, the molecular mechanisms underlying the aggressive nature of these tumors has not been fully elucidated. To investigate this further, we have used a transgenic mouse model of ErbB2-driven tumor progress...
ORGANISM(S): Mus musculus 
2013-06-02 | E-GEOD-37954 | biostudies-arrayexpress
ProteomicsN-Glycosylation of the Epidermal Growth Factor Receptor (EGFR) Derived from Human Oral Squamous Carcinoma Cells with beta-Catenin/CREB-Binding Protein (CBP) Inhibition
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy in the world; oral squamous cell carcinomas (OSCC) account for the majority of HNSCC cases. A major driver of OSCC is the epidermal growth factor receptor (EGFR), a receptor tyrosine kinase (RTK) with 12 N-glycosylatio...
ORGANISM(S): Homo sapiens (Human) 
2020-03-26 | PXD017060 | Pride
Human Beta-catenin/cbp inhibition Head and neck cancer Glycoproteomics Hsc-3 Glycopeptide Oral squamous cell carcinoma Oscc Egfr Lc-ms/ms Epidermal growth factor receptor Creb-binding protein Cal27 
Unknownβ-Catenin/CBP inhibition alters epidermal growth factor receptor fucosylation status in oral squamous cell carcinoma.
Not available
S-EPMC7299767 | biostudies-literature
UnknownCBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer.
Not available
S-EPMC6315782 | biostudies-literature
UnknownPBA2, a novel inhibitor of the β-catenin/CBP pathway, eradicates chronic myeloid leukemia including BCR-ABL T315I mutation.
Not available
S-EPMC11438308 | biostudies-literature
Unknownβ-catenin/CBP activation of mTORC1 signaling promotes partial epithelial-mesenchymal states in head and neck cancer.
Not available
S-EPMC10527608 | biostudies-literature
UnknownInhibition of Cyclic Adenosine Monophosphate (cAMP)-response Element-binding Protein (CREB)-binding Protein (CBP)/β-Catenin Reduces Liver Fibrosis in Mice.
Not available
S-EPMC4740320 | biostudies-literature
Sort   by:  
 Page size